← Back to Methodology
RQS Scoring Log

Epitalon

Longevity & Cellular Aging· Observational· Scored May 2026· View compound profile →
39 /100
Weak Evidence
7 dimensions · 100 points total · Methodology by PeptideClear
Dimension Breakdown
DimensionScoring NotesScore
Study Design
Human observational and some controlled trials primarily by Khavinson group (St. Petersburg Institute of Bioregulation). Studies in elderly populations for telomere length and aging biomarkers. No Western RCT.
15 / 25
Sample Size
Individual studies typically 30-80 elderly subjects. Small by modern standards.
8 / 20
Replication
Overwhelmingly single-institution — Vladimir Khavinson and St. Petersburg Institute of Bioregulation. This is the canonical single-institution replication case; same-institution multiple studies score 2/20.
2 / 20
Journal Impact Factor
Published in Bulletin of Experimental Biology and Medicine, Neuroendocrinology Letters. Low Western IF journals.
1 / 15
Funding Independence
Russian government and institute funded. Independent from commercial pharmaceutical industry.
7 / 10
Population Diversity
Elderly Russian populations. Reasonably diverse within elderly cohort but narrow geographic/ethnic base.
3 / 5
Researcher h-Index
Vladimir Khavinson has a notable h-Index within Russian gerontology literature (~30+ in Russian databases) but lower visibility in Western databases. Credible scientist within his field.
3 / 5
Russian Literature Note
A significant portion of evidence for this compound is published in Russian-language journals. Lower Journal Impact Factor scores reflect the publishing system, not necessarily the quality of the underlying science.